• Free US shipping on orders $75.00+
  • 10% off your first order
  • Ships by USPS Priority within 1 business day after payment is confirmed
Laboratory science · 8 min read

Pyroglutamate Formation in Peptides: N-Terminal Gln, Glu and Detection

Pyroglutamate (pGlu, also written Glp or 5-oxoproline) forms when an N-terminal glutamine or glutamic acid closes into a five-membered lactam. Glutamine does this quickly in solution; glutamic acid is much slower. This guide covers the chemistry, rates, worked mass and half-life arithmetic, detection by MS and RP-HPLC, the difference from side-chain deamidation, and a practical record checklist.

General laboratory-science education. Not medical advice. Sealed Peptides materials are for in-vitro and laboratory research use only, and are not for human or veterinary use.

What pyroglutamate is

Pyroglutamate (pGlu, also abbreviated Glp, or named 5-oxoproline) is a five-membered lactam. In a peptide it appears when the side chain of an N-terminal glutamine (Gln) or glutamic acid (Glu) reacts with the free α-amino group and closes a ring. The primary amine is removed, so Edman sequencing is blocked and the N-terminus no longer carries a positive charge at neutral pH.

From Gln the leaving group is ammonia; from Glu it is water. Both routes produce the same pyroglutamate residue. Some peptides are synthesized or isolated already carrying pGlu — ARA-290 is listed with the sequence pGlu-Glu-Gln-Leu-Glu-Arg-Ala-Leu-Asn-Ser-Ser — while others start as free Gln or Glu and can convert in solution.

Spontaneous cyclization: Gln is fast, Glu is slow

N-terminal glutamine cyclizes spontaneously under ordinary aqueous conditions. In dilute aqueous solution at pH 6.5 the first-order rate constant is about 10⁻⁶ s⁻¹ for Gln and about 10⁻⁹ s⁻¹ for Glu, a difference of roughly three orders of magnitude.[1] That puts the spontaneous half-life of N-terminal Gln near eight days under those conditions, versus many years for N-terminal Glu.

Model peptides and antibody sequences with N-terminal Gln convert readily; in one study the cyclization was spontaneous, strongly temperature- and buffer-dependent, and only weakly pH-dependent, and more than 95% conversion of N-terminal glutamine was observed under common process conditions.[2] Phosphate ions accelerate the glutamine reaction by helping synchronized proton transfers, in a way that parallels the enzyme.[8]

N-terminal glutamic acid is slower but still observable. In immunoglobulin chains, pyroglutamate from N-terminal Glu was detected after weeks at 37 and 45 °C; the half-life of the N-terminal Glu was about nine months in a pH 4.1 buffer at 45 °C, with least formation near pH 6.2 and more at pH 4 and pH 8.[3] Formulation work on a recombinant antibody likewise found non-enzymatic Glu cyclization favored at pH 4 and 8 and less common near neutral pH.[4]

Sequence, pH, temperature and enzymes

N-terminal cyclization needs a free α-amine, so an acetylated or otherwise blocked N-terminus cannot form pGlu this way. Only the first residue matters for this reaction; an internal Gln is a deamidation candidate, not a pyroglutamate candidate.

Temperature raises the rate for both Gln and Glu paths. Buffer composition matters: phosphate can catalyze the Gln reaction, while the Glu path shows a clear pH minimum near neutrality.[3, 8] See the buffers and pH guide when choosing a buffer for sequences that start with Gln or Glu.

In biology, glutaminyl cyclases accelerate N-terminal Gln (and, more weakly, Glu) cyclization during peptide maturation. A mammalian glutaminyl cyclase was identified that converts glutaminyl peptides to pyroglutamyl peptides,[6] and the human enzyme structure shows how the active site binds substrate.[7] On the bench, spontaneous chemistry usually dominates once a purified peptide sits in buffer; enzymatic rates matter when interpreting samples that still contain cyclase activity.

Worked example: mass shifts and half-life arithmetic

Mass first. Cyclization of N-terminal Gln loses NH₃ (−17.026 Da). Cyclization of N-terminal Glu loses H₂O (−18.010 Da). Both products are pGlu, so a Gln-starting peptide and a Glu-starting peptide that fully convert end at the same residue mass from different starting points.

Take ARA-290 (pGlu-Glu-Gln-Leu-Glu-Arg-Ala-Leu-Asn-Ser-Ser). Its listed molecular weight is about 1,257 Da, matching a pyroglutamate N-terminus. The corresponding free-Gln form would be heavier by 17.026 Da (about 1,274 Da monoisotopic). At the [M+2H]²⁺ charge state, that is a shift of about 8.5 m/z. The peptide mass calculator gives the free-amine mass; subtract 17.026 Da (Gln) or 18.010 Da (Glu) for the pGlu form.

Kinetics next, using the pH 6.5 spontaneous rate for N-terminal Gln (k ≈ 10⁻⁶ s⁻¹, t½ ≈ 8.0 days).[1] First-order remaining fraction is 2^(−t / t½). After 1 day about 8% has cyclized; after 7 days about 45%; after 30 days about 93%. For N-terminal Glu under the same reference conditions (k ≈ 10⁻⁹ s⁻¹) the same 30 days convert only a small fraction of a percent. Numbers are illustrative for that aqueous model; real buffers, temperature and sequence shift the rate, as the antibody Glu data at 45 °C show.[3]

Detection by mass spectrometry and RP-HPLC

In a mass spectrum, look for a species 17.026 Da (from Gln) or 18.010 Da (from Glu) below the free N-terminal peptide. Because the N-terminal charge is lost, the charge-state distribution can also shift toward lower charge. Collision-induced dissociation of peptides that start with Glu or Gln often shows early water or ammonia loss and altered b₂ / yₙ₋₂ patterns compared with other N-terminal residues.[5] See reading mass spectrometry results.

In reversed-phase HPLC, the pGlu form often separates from the free-amine form because hydrophobicity and charge both change. Light-chain pGlu and free-Glu species of reduced antibodies were resolved by RP-HPLC-MS, with identity confirmed by peptide mapping.[3] A single symmetric peak does not prove the N-terminus is homogeneous — co-elution happens — so pairing RP-HPLC with accurate mass is the usual check. See reading an HPLC chromatogram.

Distinction from deamidation

Deamidation of Asn or Gln adds 0.984 Da and leaves a free N-terminus. Pyroglutamate formation subtracts 17 or 18 Da and blocks that terminus. An internal Gln can deamidate to Glu; only an N-terminal Gln or Glu can form pGlu by this ring closure. For the succinimide route, isoaspartate and the +0.984 Da isotope overlap, see the peptide deamidation guide. The two modifications can coexist on different sites of the same molecule, so both mass windows are worth inspecting.

Practical handling and a record checklist

Practical points: keep Gln-starting peptides lyophilized and cold until needed; prepare solutions shortly before use; watch phosphate buffers if you need to hold a free N-terminal Gln; remember that Glu-starting sequences are slower but not immune, especially at elevated temperature and at acidic or basic pH; and treat a listed pGlu sequence (as with ARA-290) as already cyclized for mass calculations. For results to be interpretable, record:

  • Sequence. Whether position 1 is Gln, Glu or pGlu, and whether the N-terminus is acetylated or otherwise blocked.
  • Solution conditions. Buffer species and concentration (especially phosphate), pH, temperature and time in solution before analysis.
  • Mass data. Expected free-amine and pGlu masses, observed −17.026 or −18.010 Da species, and charge-state distribution.
  • Chromatography. RP-HPLC method, whether free-amine and pGlu forms separate, and a fresh reference analysed the same day.

This guide describes general laboratory chemistry and published literature only. It is not a statement about the content or behaviour of any particular material. Related degradation routes are covered in peptide storage and degradation and peptide deamidation; terms are defined in the glossary; questions can be sent to support.

Terms used in this guide

Related tools and guides

References

  1. Seifert F, Schulz K, Koch B, Manhart S, Demuth HU, Schilling S. Glutaminyl cyclases display significant catalytic proficiency for glutamyl substrates. Biochemistry. 2009;48(50):11831-3. PMID 19921850 · DOI
  2. Dick LW Jr, Kim C, Qiu D, Cheng KC. Determination of the origin of the N-terminal pyro-glutamate variation in monoclonal antibodies using model peptides. Biotechnol Bioeng. 2007;97(3):544-53. PMID 17099914 · DOI
  3. Chelius D, Jing K, Lueras A, Rehder DS, Dillon TM, Vizel A, Rajan RS, Li T, Treuheit MJ, Bondarenko PV. Formation of pyroglutamic acid from N-terminal glutamic acid in immunoglobulin gamma antibodies. Anal Chem. 2006;78(7):2370-6. PMID 16579622 · DOI
  4. Yu L, Vizel A, Huff MB, Young M, Remmele RL Jr, He B. Investigation of N-terminal glutamate cyclization of recombinant monoclonal antibody in formulation development. J Pharm Biomed Anal. 2006;42(4):455-63. PMID 16828250 · DOI
  5. Godugu B, Neta P, Simón-Manso Y, Stein SE. Effect of N-terminal glutamic acid and glutamine on fragmentation of peptide ions. J Am Soc Mass Spectrom. 2010;21(7):1169-76. PMID 20413325 · DOI
  6. Fischer WH, Spiess J. Identification of a mammalian glutaminyl cyclase converting glutaminyl into pyroglutamyl peptides. Proc Natl Acad Sci U S A. 1987;84(11):3628-32. PMID 3473473 · DOI
  7. Huang KF, Liu YL, Cheng WJ, Ko TP, Wang AH. Crystal structures of human glutaminyl cyclase, an enzyme responsible for protein N-terminal pyroglutamate formation. Proc Natl Acad Sci U S A. 2005;102(37):13117-22. PMID 16135565 · DOI
  8. Seifert F, Demuth HU, Weichler T, Ludwig HH, Tittmann K, Schilling S. Phosphate ions and glutaminyl cyclases catalyze the cyclization of glutaminyl residues by facilitating synchronized proton transfers. Bioorg Chem. 2015;60:98-101. PMID 25981125 · DOI

Cited literature is provided for scientific context only. Many of these reviews concern proteins or pharmaceutical development; they are cited for general chemistry and do not describe or endorse any use of these products.

For laboratory research use only. Not for human or veterinary use. This page is general chemistry education and does not describe or endorse any use of Sealed Peptides products. Cited literature is provided for scientific context only.

Guide FAQ

What is pyroglutamate in a peptide?

Pyroglutamate (pGlu, Glp, 5-oxoproline) is a five-membered lactam formed when the N-terminal residue cyclizes. From glutamine the side-chain amide attacks the α-amino group and ammonia leaves; from glutamic acid the side-chain carboxyl does the same and water leaves. The N-terminus loses its free primary amine and its positive charge at neutral pH.

Why is N-terminal Gln much faster than N-terminal Glu?

At pH 6.5 the spontaneous first-order rate constant for glutamine cyclization is about 10⁻⁶ s⁻¹, while that for glutamic acid is about 10⁻⁹ s⁻¹ — roughly a thousand-fold slower. Phosphate and related buffers can accelerate the glutamine reaction by helping proton transfers.

What mass shift should I look for?

Cyclization of N-terminal Gln loses ammonia (−17.026 Da). Cyclization of N-terminal Glu loses water (−18.010 Da). Both products are the same pyroglutamate residue, so the two paths meet at the same chemical end point with different mass signatures from their starting residues.

How is pyroglutamate different from deamidation?

Deamidation converts an asparagine or glutamine side chain into Asp or Glu and adds 0.984 Da; the backbone N-terminus is unchanged. Pyroglutamate formation requires a free N-terminal Gln or Glu, closes a ring onto that terminus, and subtracts 17 or 18 Da. Internal Gln can deamidate; only N-terminal Gln or Glu can form pGlu spontaneously in this way.

Who is this guide written for?

Laboratory staff and researchers handling research-use-only materials. "Pyroglutamate Formation in Peptides: N-Terminal Gln, Glu and Detection" covers laboratory practice only and describes no use of any product in people or animals.

Does Sealed Peptides give usage advice?

No. Our guides and calculators cover laboratory handling, analysis and unit arithmetic only. All products are sold for laboratory research use only.

Is there a calculator that goes with this guide?

Yes: Peptide mass calculator, Storage reference tables, Peptide properties calculator. They run free in the browser with no signup.

How are lyophilized research peptides usually stored?

Lyophilized powders are generally kept sealed, dry, protected from light and frozen (around -20°C). Each product page lists its stated storage condition, and our peptide storage guide explains the reasoning.

More answers: Site FAQ · Storage guide · Storage reference tables

Explore Sealed Peptides

Coming soon: Epitalon · Thymosin Alpha-1 · Glutathione · ARA-290